Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication
Tobias Moll, Valerie Odon, Calum Harvey, Mark O. Collins, Andrew A. Peden, John Franklin, Emily J Graves, Jack N.G. Marshall, Cleide Dos Santos Souza, Sai Zhang, Lydia M. Castelli, Guillaume M. Hautbergue, Mimoun Azzouz, David Ezra Gordon, Nevan J. Krogan, , Johnathan Cooper‐Knock
The paper identifies reduced EXOSC2 expression as protective against SARS-CoV-2 infection and clinical COVID-19 by inhibiting viral replication and upregulating antiviral genes.
Life Science Alliance · Oct 14, 2022Peer-reviewedGenetics